Retinal Neovascularization Clinical Trial
Official title:
Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy
The purpose of this study is to determine the efficacy in the use of topical Squalamine Lactate Ophthalmic Solution, 0.2% in the treatment of retinal neovascularization resulting from proliferative diabetic retinopathy.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650047 -
Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
|
||
| Recruiting |
NCT05130385 -
High Resolution Optical Coherence Tomography
|
||
| Recruiting |
NCT03211741 -
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
|
Phase 4 | |
| Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
| Terminated |
NCT02088151 -
Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
|
N/A | |
| Completed |
NCT00564148 -
Intravitreal Avastin in Proliferative Retinopathies
|
Phase 2 | |
| Completed |
NCT02876198 -
Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF
|
||
| Completed |
NCT01024998 -
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
|
Phase 1 | |
| Completed |
NCT01102946 -
Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
|
Phase 2 | |
| Completed |
NCT04650672 -
Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.
|
||
| Completed |
NCT01494805 -
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
|
Phase 1/Phase 2 | |
| Completed |
NCT00000153 -
Krypton-Argon Regression of Neovascularization Study (KARNS)
|
Phase 3 |